Vault nanoparticles engineered with the protein transduction domain, TAT48, enhances cellular uptake

Integrative Biology (United Kingdom)

Volumn 5, Issue 1, 2013, Pages 151-158

  Yang, Jian ^a   Srinivasan, Aswin ^a   Sun, Yang ^a   Mrazek, Jan ^a   Shu, Zhanyong ^b   Kickhoefer, Valerie A ^a   Rome, Leonard H ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Molecular Cellular Developmental Biology David Geffen School of Medicine at UCLA ^*  (United States)

^c CALIFORNIA NANOSYSTEMS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PENETRATING PEPTIDE; NANOPARTICLE; RIBONUCLEOPROTEIN; TAT48 PROTEIN VAULT NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BIOENGINEERING; CANCER CELL; CANCER LOCALIZATION; CELL MEMBRANE; CELL PERMEABILIZATION; CELL TRANSPORT; CELLS; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN ENGINEERING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EUKARYOTA;

EID: 84871725121     PISSN: 17579694     EISSN: 17579708     Source Type: Journal    
DOI: 10.1039/c2ib20119d     Document Type: Article

References (43)

1. B. W. Stewart and P. Kleihues, World Cancer Report, World Health Organization Press, Geneva, 2003
2. American Cancer Society, Cancer Facts & Figures, American Cancer Society, Atlanta, 2011
3. C. M. Hu L. Zhang Therapeutic nanoparticles to combat cancer drug resistance Curr. Drug Metab. 2009 10 8 836 41
4. D. Peer et al., Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2007 2 12 751 760
5. V. Wagner et al., The emerging nanomedicine landscape Nat. Biotechnol. 2006 24 10 1211 1217
6. M. E. Davis Z. Chen D. M. Shin Nanoparticle therapeutics: an emerging treatment modality for cancer Nat. Rev. Drug Discovery 2008 7 9 771 782
7. A. Z. Wang R. Langer O. C. Farokhzad Nanoparticle delivery of cancer drugs Annu. Rev. Med. 2012 63 185 98
8. M. Ferrari Cancer nanotechnology: opportunities and challenges Nat. Rev. Cancer 2005 5 3 161 71
9. E. White et al., A phase I trial of carboplatin administered by convection-enhanced delivery to patients with recurrent/progressive glioblastoma multiforme Contemporary Clinical Trials 2012 33 2 320 31
10. E. White et al., An evaluation of the safety and feasibility of convection-enhanced delivery of carboplatin into the white matter as a potential treatment for high-grade glioma J. Neuro-Oncol. 2012 108 1 77 88
11. S. Murata et al., Ductal access for prevention and therapy of mammary tumors Cancer Res. 2006 66 2 638 45
12. W. H. Roa et al., Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model J. Controlled Release 2011 150 1 49 55
13. U. K. Kar et al., Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth PLoS One 2011 6 5 e18758
14. K. A. Suprenant Vault ribonucleoprotein particles: sarcophagi, gondolas, or safety deposit boxes? Biochemistry 2002 41 49 14447 54
15. V. A. Kickhoefer et al., Vaults and telomerase share a common subunit, TEP1 J. Biol. Chem. 1999 274 46 32712 7
16. V. A. Kickhoefer et al., The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase J. Cell Biol. 1999 146 5 917 28
17. N. L. Kedersha et al., Vaults. III. Vault ribonucleoprotein particles open into flower-like structures with octagonal symmetry J. Cell Biol. 1991 112 2 225 35
18. V. A. Kickhoefer et al., Vault ribonucleoprotein particles from rat and bullfrog contain a related small RNA that is transcribed by RNA polymerase III J. Biol. Chem. 1993 268 11 7868 73
19. V. A. Kickhoefer et al., Vaults are up-regulated in multidrug-resistant cancer cell lines J. Biol. Chem. 1998 273 15 8971 4
20. A. van Zon et al., Multiple human vault RNAs. Expression and association with the vault complexm J. Biol. Chem. 2001 276 40 37715 21
21. W. Berger et al., Vaults and the major vault protein: novel roles in signal pathway regulation and immunity Cell. Mol. Life Sci. 2009 66 1 43 61
22. A. G. Stephen et al., Assembly of vault-like particles in insect cells expressing only the major vault protein J. Biol. Chem. 2001 276 26 23217 20
23. M. Han et al., Targeted Vault Nanoparticles Engineered with an Endosomolytic Peptide Deliver Biomolecules to the Cytoplasm ACS Nano 2011
24. M. J. Poderycki et al., The vault exterior shell is a dynamic structure that allows incorporation of vault-associated proteins into its interior Biochemistry 2006 45 39 12184 93
25. L. E. Goldsmith et al., Vault nanocapsule dissociation into halves triggered at low pH Biochemistry 2007 46 10 2865 75
26. R. Esfandiary et al., Structural stability of vault particles J. Pharm. Sci. 2009 98 4 1376 86
27. J. Yang et al., Vaults are dynamically unconstrained cytoplasmic nanoparticles capable of half vault exchange ACS Nano 2010 4 12 7229 40
28. K. M. Stewart K. L. Horton S. O. Kelley Cell-penetrating peptides as delivery vehicles for biology and medicine Org. Biomol. Chem. 2008 6 13 2242 2255
29. L. N. Patel J. L. Zaro W. C. Shen Cell penetrating peptides: Intracellular pathways and pharmaceutical perspectives Pharm. Res. 2007 24 11 1977 1992
30. V. P. Torchilin Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers Adv. Drug Delivery Rev. 2008 60 4-5 548 558
31. X. K. Zhang X. Zhang F. S. Wang Intracellular transduction and potential of Tat PTD and its analogs: from basic drug delivery mechanism to application Expert Opin. Drug Delivery 2012 9 4 457 472
32. Y. Mikyas et al., Cryoelectron microscopy imaging of recombinant and tissue derived vaults: localization of the MVP N termini and VPARP J. Mol. Biol. 2004 344 1 91 105
33. V. A. Kickhoefer et al., Engineering of vault nanocapsules with enzymatic and fluorescent properties Proc. Natl. Acad. Sci. U. S. A. 2005 102 12 4348 52
34. D. H. Anderson et al., Draft crystal structure of the vault shell at 9-angstrom resolution PLoS Biol. 2007 5 11 2661 2670
35. B. C. Ng et al., Encapsulation of semiconducting polymers in vault protein cages Nano Lett. 2008 8 10 3503 9
36. C. I. Champion et al., A vault nanoparticle vaccine induces protective mucosal immunity PLoS One 2009 4 4 e5409
37. L. E. Goldsmith et al., Utilization of a protein "shuttle" to load vault nanocapsules with gold probes and proteins ACS Nano 2009 3 10 3175 83
38. V. A. Kickhoefer et al., Targeting vault nanoparticles to specific cell surface receptors ACS Nano 2009 3 1 27 36
39. C. Y. Lai et al., Vault nanoparticles containing an adenovirus-derived membrane lytic protein facilitate toxin and gene transfer ACS Nano 2009 3 3 691 9
40. Y. Xia et al., Immobilization of recombinant vault nanoparticles on solid substratesm ACS Nano 2010 4 3 1417 24
41. D. C. Buehler et al., Vaults engineered for hydrophobic drug delivery Small 2011 7 10 1432 9
42. Y. L. Lin et al., Heparin inhibits dengue-2 virus infection of five human liver cell lines Antiviral Res. 2002 56 1 93 96
43. J. A. Gomez et al., Cell-Penetrating Penta-Peptides (CPP5s): Measurement of Cell Entry and Protein-Transduction Activity Pharmaceuticals (Basel) 2010 3 12 3594 3613